Researchers at Helmholtz Munich have identified a new source of stem cells in the brains of patients with brain injuries, which could lead to improved treatments for neurological disorders. The discovery involves specific astrocyte cells that exhibit properties of neural stem cells and can be regulated by a protein called Galectin 3.
A new experimental model, human precision-cut lung slices (hPCLS), was used to study lung disease mechanisms and understand treatment response. The team leveraged single-cell genomics to analyze cell activity in hPCLS after specific treatments.
Researchers from Helmholtz Munich discovered that GIP decreases body weight by interacting with specific inhibitory neurons in the brain, offering a revolutionary approach to patients worldwide. The study reveals the underlying molecular mechanisms of GIPR:GLP-1R co-agonists and their potential as next-generation anti-obesity drugs.
A new generative model named scPoli enables multi-scale representations of cells and samples, facilitating the integration of high-quality large-scale datasets for novel biological insights and disease understanding. This model accelerates atlas building and usage, ultimately accelerating disease understanding and therapy development.
Researchers have developed DeepMB, a neural network that reconstructs high-quality optoacoustic images about 1,000 times faster than state-of-the-art algorithms. This enables clinicians to access optimal MSOT image quality in real-time, positively impacting clinical studies and patient care.
Researchers at Helmholtz Munich discovered how exercise influences muscle function, immune cells, and metabolism in conditions like obesity and type 2 diabetes. They found that regulatory T cells play a critical role in controlling muscle function and regeneration.
Researchers at Helmholtz Munich developed a non-invasive method using MR imaging to detect early signs of vascular disease associated with chronic pulmonary impairment in premature infants. The study presents a new tool for risk stratification and potential prevention of complications later in life.
Researchers from Helmholtz Munich and TU Dresden develop AI-powered biomarker detection that outperforms previous approaches. The algorithm achieves high sensitivity on resection tissue samples and shows promise as a pre-screening tool for biopsy tissue.
Scientists discover unique immune cells in skull's bone marrow, facilitating movement of immune cells between brain and skull, offering new possibilities for diagnosing and treating neurological diseases. Non-invasive skull imaging may enable early detection and monitoring of conditions like Alzheimer's and stroke.
Researchers at Helmholtz Munich discovered that DHODH inhibitors sensitize cancer cells to ferroptosis by inhibiting ferroptosis suppressor protein-1 (FSP1), not DHODH itself. This finding confirms the crucial role of FSP1 in ferroptosis surveillance and opens up new avenues for developing effective cancer therapies.
Researchers discovered icFSP1, a novel anti-cancer drug that sensitizes cancer cells to ferroptosis by triggering phase separation of FSP1. This mechanism-of-action has great promise for combating tumors and offers a new concept in cancer therapy.
Researchers discovered that tirzepatide stimulates insulin secretion in human pancreatic islets through the GIP receptor. This finding contrasts with previous studies in mice, which showed that tirzepatide primarily stimulated insulin secretion via the GLP-1 receptor.
A study found that children with COVID-19 were 57% more likely to develop type 1 diabetes, with the increase occurring shortly after the virus diagnosis. The researchers hope to explore this correlation further using prospective cohorts of children.
Researchers found an increased risk of death due to respiratory disease five to seven days after exposure to ultrafine particles. The risk was highest for smaller particle sizes, with a 4.46% increase in mortality for each 3,223 particles per cubic centimeter concentration.
A bacterial molecule, ARBM101, has been found to efficiently lower liver copper levels in a rat model, offering a promising new therapeutic option for Wilson's disease. The treatment approach involves weekly applications followed by month-long breaks, significantly shortening the therapy period.
Researchers have identified two potential molecular targets, CSF1R and CD86, that can be used to develop CAR-T cells effective against acute myeloid leukemia. The study's findings demonstrate the potential of AI-assisted analysis in discovering new treatment options.
Researchers at Helmholtz Munich discovered a new protein called Cited1 that plays a crucial role in regulating energy homeostasis and sensitivity to satiety hormones. The study found that females are better protected against obesity due to their higher levels of estrogens, which regulate energy metabolism through the hypothalamus.
A study published in Journal of Hepatology found that efficient priming of HBV-specific CD4 T cells is crucial for the success of therapeutic hepatitis B vaccination. The researchers developed a novel heterologous prime-boost vaccine, TherVacB, which induced antiviral efficacy in preclinical mouse models.
Researchers discovered that MODY3 patients experience hypersecretion of insulin from β cells due to more efficient membrane depolarization. This phenomenon precedes pancreatic β cell failure and can be targeted for prevention or delay with treatments, such as diets or drugs.
Researchers developed a new spatial-omics technology called DISCO-MS to detect early molecular changes in diseases. This approach allows for the characterization of diseased cells in intact tissues, revealing new biomarkers and therapeutic targets for conditions like Alzheimer's disease and atherosclerosis.
A new reporter system called INSPECT allows for highly sensitive monitoring of both coding and non-coding RNA production, shedding light on cellular processes. This breakthrough tool modifies introns without altering completed RNA or proteins, offering a minimally invasive solution to study RNA regulation.
Researchers developed a new method to represent cell communication using graph neural networks, which uncovers the effects of tissue niche composition on gene expression. The node-centric expression models (NCEMs) identify cell-cell dependencies and molecular processes underlying cell communication.
A team of scientists has identified over 200 direct protein-protein contacts between the SARS-CoV-2 virus and human cells, shedding light on the mechanisms underlying severe COVID-19. The study reveals chains of connections between viral proteins and infection-relevant human genes, with implications for disease severity and treatment.
Helmholtz Munich researchers identified a novel strategy to alter glucagon receptor signaling by changing its intracellular localization. This approach offers therapeutic potential for treating type 2 diabetes by uncoupling glucose and lipid metabolism-related effects.
A long-term study on infants and young children with increased genetic risk of type 1 diabetes found that metabolic changes occur much earlier than previously assumed. Blood sugar levels were found to be higher in children who developed autoimmunity, suggesting a potential indicator for islet cell dysfunction.
Researchers developed an AI algorithm that can learn independently from multiple medical institutions without compromising data privacy. The algorithm outperformed traditional methods and has the potential to revolutionize digital medicine by reducing radiologists' workloads and making AI-based solutions more affordable.
Researchers at Helmholtz Munich discover vitamin K's ability to inhibit ferroptotic cell death and identify the warfarin-insensitive enzyme FSP1. This finding may lead to novel therapeutic strategies for diseases associated with ferroptosis.
Researchers at Helmholtz Munich found that centrosome protein composition differs between cell types, leading to disease relevance. A specific protein's location is crucial for its role in neuronal diseases.
The oat genome has been fully sequenced, revealing key genes responsible for its health-promoting properties, including beta-glucans that reduce cholesterol and alleviate metabolic diseases. This breakthrough enables targeted breeding for more nutritious and sustainable oats.
Researchers at Helmholtz Munich have discovered that slowing down DNA replication speed improves reprogramming efficiency of cells into totipotent cells. This breakthrough could be a major advancement for stem cell therapy and regenerative medicine approaches.
A recent study found that early detection of type 1 diabetes in children can effectively monitor and treat the disease. The cost analysis shows that standard screening could reduce costs from 28 euros to 22 euros per child, while also preventing metabolic derailments and their consequences.
Researchers at Helmholtz Munich have discovered a crucial link between the immune system and metabolic response to fasting. By examining liver cells and immune cells, they found that immune cells can directly influence the effect of fasting on metabolism through a key molecule called the glucocorticoid receptor.
Researchers discovered how different tissues respond to exercise at various times of day, influencing sleep, memory, and metabolic homeostasis. The 'Atlas of Exercise Metabolism' provides a comprehensive map of exercise-induced signaling molecules present in different tissues following exercise.
Researchers developed photoswitchable label proteins to visualize small numbers of cells in live organisms, enabling improved understanding of diseases like the immune system or tumor development. They also created sensors for optoacoustic and super-resolution imaging to visualize small molecules or ions at nanometer resolution.
The Helmholtz Munich researchers developed a neural network that outperforms previous machine learning algorithms for cell classification in terms of accuracy and generalizability. The database consists of over 170,000 single-cell images from more than 900 patients with various blood diseases.
A new study reveals that a high-sugar and high-fat diet can disrupt the natural adaptation of the digestive system by accelerating the division and differentiation of intestinal stem cells. This can lead to an increased risk of obesity, type 2 diabetes, and gastrointestinal cancer.
Researchers developed scArches to compare single-cell genomics data with existing references, enabling accurate diagnosis of diseases like COVID-19. The algorithm uses transfer learning to preserve privacy and democratize the usage of single-cell reference atlases.
A large study of over 825,000 individuals has identified new genetic risk factors for osteoarthritis and pinpointed potential drug targets. The research also found specific genetic changes that underpin the risk for all forms of osteoarthritis.
Research found that cells with defective mitochondria and sequence changes in their genome are 'loser' cells in mouse embryos, suggesting that mitochondrial dysfunction is a common characteristic of competing cells. The study suggests that mitochondrial activity may be a key determinant of cellular fitness in various biological contexts.
Non-alcoholic fatty liver disease affects 25% of the global population, leading to inflammation and fibrosis. Researchers discovered that hepatocyte reprogramming is controlled by molecular switches, resulting in dysfunction.
Researchers from Helmholtz Zentrum München have discovered a novel mechanism driving the formation of the endoderm germ layer during gastrulation. This finding has significant implications for understanding congenital diseases and potential targets for therapeutic intervention in cancer.
A study by an international consortium reveals the structure and mechanism of a protein that builds and maintains photosynthetic membranes in plants. The research provides new opportunities for engineering plants to be more resistant to extreme environmental conditions, helping to sustain human food supply and combat climate change.
New research reveals that obese mice do not increase the density of blood vessels in the hypothalamus when leptin is absent. However, increasing leptin levels promotes vessel growth via astrocyte activity. This study provides a paradigm shift in understanding how the hypothalamus controls blood pressure in obesity.
Scientists at Helmholtz Zentrum München developed a new bioengineered reporter system called EXSISERS, enabling non-invasive observation of fundamental cellular processes. The system detects specific protein isoforms being translated, with potential applications in neurodegenerative diseases like Parkinson's.
Researchers have demonstrated that HERV activation can impair brain development, leading to altered cortical neuron function and structure. This finding has important clinical implications, particularly in the context of neurodegenerative diseases.
A German study found that preschool and school children were more infected with SARS-CoV-2 than previously reported cases during the second wave. Antibody tests revealed a significant increase in infections among both age groups, with antibody frequencies up to eight times higher than those reported via PCR testing.
A new study reveals that SARS-CoV-2 infects cells with high expression of ACE2 receptor and protease, found in lung epithelium and other organs. The study suggests that elderly people, men, and smokers are more severely affected due to increased viral entry factor expression.
Researchers have discovered a novel and druggable insulin inhibitory receptor named inceptor. Blocking its function leads to increased sensitisation of the insulin signalling pathway in pancreatic beta cells, allowing for potential protection and regeneration of beta cells for diabetes remission.
Researchers improved understanding of intestinal stem cells' renewal and differentiation into specialized cell types. They identified a specific Wnt/planar cell polarity pathway regulating intestinal stem cell self-renewal and lineage decisions, crucial for treating diseases like diabetes and colorectal cancer.
Researchers developed an animal-free method to predict nanoparticle toxicity, enabling safer industrial materials production and reducing environmental risks. The new approach identifies key cellular events triggering inflammation, allowing for high-throughput testing and connectable with in silico modeling.